Association of Community Cancer Centers (ACCC) 46th Annual Meeting & Cancer Center Business Summit to Examine Most Important Topics in Cancer Care Delivery Today

In today’s competitive oncology marketplace, staying productive and economically viable remains a significant challenge. Key stakeholders—together with business, policy, and technology thought leaders—will convene to explore cutting-edge solutions for growth and sustainability in an evolving healthcare environment and the fast-changing cancer care landscape.

What: Association of Community Cancer Centers 46^th Annual Meeting & Cancer Center Business Summit

When: March 4-6, 2020

Where: Washington Hilton, DC

Sessions will tackle programmatic challenges and inspire new ways of approaching the critical demands of delivering care in an era of rapid-speed advances in science, technology, and knowledge and turbulent policy and regulatory change. General sessions will offer novel approaches to forecasting—and preparing for —shifts in oncology; breakout sessions will provide strategic insights. Compelling keynote speakers and peer-to-peer session facilitators will share their expertise, effective practices, and help translate strategic insights into actionable takeaways.

Featured Sessions:

Disruptive Innovations That Could Change the Delivery of Cancer Care
Susan Dentzer, Senior Policy Fellow, Duke-Margolis Center for Health Policy

Respected healthcare policy analyst Susan Dentzer will share her vision for the future of cancer care, the technology trends and healthcare delivery platforms on the horizon, and the opportunities—and barriers—to building an effective infrastructure that supports innovation.

A Conversation About the State of Healthcare in the United States
U.S. Senator Debbie Stabenow (D-MI)

Senator Debbie Stabenow, a senior member of the Senate Finance Committee, Energy Committee, and Budget Committee, shares perspectives about her role in shaping our nation’s healthcare, including expanding affordable healthcare and lowering the costs of prescription drugs.

Applied Informatics in Oncology
Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology; Medical Director, McKesson Specialty Health; Editor-in-Chief, ASCO JCO Journal of Clinical Cancer Informatics

Drawing from her decades-long experience in health economics, outcomes research, and clinical informatics, Dr. Patt will share the latest developments and breakthroughs in decision support and predictive analytics in oncology that are improving quality and increasing value in oncology care. She will outline practical tips and best practices for the application of multiple integrated data assets to understand cancer outcomes and to move the needle forward in value-based cancer care.

"Direct to Patient” Engagement in Oncology—What It Is and How to Achieve It

Kraft Precision Medicine Accelerator, a program out of the Harvard Business School
Lori Marcus, Direct-to-Patient Workstream Lead, Kraft Precision Medicine Accelerator
Anne Quinn Young, MPH, Chief Marketing and Development Officer, Multiple Myeloma Research Foundation

What opportunities can “direct to consumer” bring to oncology? Following a large-scale, pan-oncology market research project, Kraft developed a comprehensive, “direct to patient” road map to help patients navigate their cancer journey, close knowledge gaps, and optimize outcomes. Non-profit provider organizations have overwhelmingly endorsed—and are working to roll out—the  model. The session will outline a “direct to patient” model, including practical and operational obstacles and solutions.

Breakout Sessions:

Seeking Greener Pastures: What Motivates Oncologists to Change Practice Setting and Where Do They Go?

Engaging Physician Leaders for the Future of Oncology

Costs and Benefits of Palliative Care in the Hospital, Clinic, and Home

Preparing for the Value-Based Enterprise: Practical Legal and Valuation Tips for the New Paradigm

Leveraging APPs to Improve Care Delivery and the Patient Experience

Urgent Care for Cancer Patients: Reducing ED Visits and Hospitalizations

Expanding Your Horizons: Transactional Issues in Hospital/Physician Alignment

Telehealth: Opportunities and Challenges in Oncology

Lost in Translation: Design Implications for Multidisciplinary Cancer Care

The Role of Private Equity Sponsors in Oncology

Building and Sustaining a Financially Viable Clinical Trials Program Through Technology

National Evidence-Based Oncology Navigation Metrics Demonstrate Value and Sustainability of Navigation Programs

Deep Dive Workshops:

Interactive, bi-directional learning on hot button issues in the delivery of cancer care. Participants will define, dissect, and brainstorm on identified challenges and opportunities.

Immuno-Oncology in 2020: What We’ve Learned and What’s Ahead

Disruption in Drug Delivery and Pricing

Digital Health Revolution

March 4 Pre-Conferences:

Radiation Oncology
Sessions explore forward-thinking strategies necessary for supporting radiation oncology program viability and innovation. Multidisciplinary discussions will address the critical issues—and opportunities—facing today’s radiation oncology practices and programs.

Surgical Oncology
Through the examination of case studies, sessions will explore the drivers and obstacles, building blocks, costs, and effective practices of a successful surgical oncology program.

Full agenda and meeting details are available here.

###

This event is co-hosted by the Association of Community Cancer Centers, Cancer Center Business Development Group, and Foley & Lardner LLP.

About Cancer Center Business Development Group

The Cancer Center Business Development Group provides business and financial advisory expertise to stakeholders in the delivery of cancer care. Practice partnering strategies. Planning, development and operational transformation of comprehensive service lines/cancer centers. Design and implementation of innovative cancer care delivery models, such as the oncology medical home and oncology specialist networks. Initiatives in value-based alternative payment models in oncology, including the Oncology Care Model (OCM) and commercial bundled pricing methodologies. ccbdgroup.com.

About Foley & Lardner LLP

Foley & Lardner LLP is a national law firm providing comprehensive legal services for innovative enterprises in the health care, pharmaceutical, biotechnology and biomedical sectors. Our health care attorneys provide counsel on financial transactions, mergers, acquisitions, affiliations, joint ventures, regulatory and government compliance, and business operations. With offices throughout the United States and the backing of Foley’s Health Care Industry Team, named “Law Firm of the Year — Health Care Law” for three years in a row by U.S. News – Best Lawyers®. Foley is well-positioned to serve the wide-ranging needs of cancer care providers and other health care organizations across the country. foley.com